By José Augusto Cabral Barros
2004

ABSTRACT

This text stems from a research project aimed at evaluating actual drug
policies particularly those related to the harmonization of regulatory processes
within the European Union and at the international level as well.
Firstly the role of drugs is evaluated in regards to pharmaceutical industry
and economic interests involved in emphasizing the “medicalization” phenomenon
viewed as a consequence of drug manufacturers promotional strategies directed
to consumers and physicians.
The second chapter is dedicated to describing harmonization of regulation
of drugs worldwide.
Moreover, the globalisation and neoliberal economic reforms and
their impact to the access to pharmaceuticals are briefly analysed, as well as
different initiatives to promote rational use and access to essential medicaments.
Finally some conclusions emerge in the light of the pharmaceutical
sector situation; an analysis is put forth, and proposals are presented in order to
improve drug usage in the interest of public health.

Next Section:
INTRODUÇÃO: Papel assumido pelos medicamentos e alguns dos seus determinantes

Previous Section:
PRÓLOGO

Books homepage

Políticas Farmaceuticas homepage

Comments

Our members can see and make comments on this page.